Parabilis Medicines Balance Sheet
NASDAQ: PBLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Parabilis Medicines has no annual balance sheet on file yet, so quarterly figures are shown instead.
Parabilis Medicines financial position
As of Jun 30, 2026, Parabilis Medicines reported total assets of $1.18 billion against total liabilities of $127.5 million. Shareholders' equity stood at $1.05 billion, or 89.1% of assets. The company held $1.09 billion in cash and equivalents against $6.4 million of debt, a net cash position of $1.08 billion.
The current ratio (current assets divided by current liabilities) was 17.91, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.01.
Summary generated from market data by MetaCap's automated system. Methodology
Parabilis Medicines balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q? 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Cash & Equivalents | 1.09B | — | 80.39M | — |
| Short-Term Investments | 33.64M | — | — | — |
| Total Current Assets | 1.13B | — | — | — |
| Property, Plant & Equipment | 6.72M | — | — | — |
| Total Assets | 1.18B | — | — | — |
| Accounts Payable | 18.52M | — | — | — |
| Short-Term Debt | 5.71M | — | — | — |
| Total Current Liabilities | 62.84M | — | — | — |
| Long-Term Debt | 700.00K | — | — | — |
| Total Liabilities | 127.53M | — | — | — |
| Shareholders' Equity | 1.05B | -570.32M | -455.41M | -421.43M |
| Retained Earnings | -639.28M | — | — | — |
| Total Debt | 6.41M | — | — | — |
| Net Cash (Debt) | 1.11B | — | 80.39M | — |
| Shares Outstanding | 121.94M | — | — | — |
This table shows 4 quarterly periods of Parabilis Medicines's balance sheet, from Q2 2026 back to Q? 2025, across 15 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow PBLS's reporting calendar. What is a balance sheet?